Endobronchial valve treatment of destructive multidrug-resistant tuberculosis.

Background: In accordance with the existing hypothesis, the application of an endobronchial valve (EbV) leads to selective curative atelectasis of the affected part of the lung, contributing to early closure of cavities.

Objective: To assess the effect of EbV treatment on the course of tuberculosis (TB).

Methods: We compared the efficacy of EbV treatment and complex second-line treatment in treating patients with destructive pulmonary multidrug-resistant TB (MDR-TB).